Health care-associated Staphylococcus aureus pneumonia

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 18, Issue 3, 2007, Pages 181-188

  Webster, Duncan ^a   Chui, Linda ^b   Tyrrell, Gregory J ^b   Marrie, Thomas J ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Community acquired pneumonia; Health care associated pneumonia; Staphylococcus aureus

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ADULT; AGED; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EMBOLISM; FEMALE; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PATHOGENESIS; PATIENT CODING; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS;

EID: 34547821506     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/136796     Document Type: Review

References (40)

1. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: Results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62. (Erratum in 2006;129:831).
2. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
3. Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA 1919;72:617-26.
4. Ede S, Davis GM, Holmes FH. Staphylococcic pneumonia. J Am Med Assoc 1959;170:638-43.
5. Finland M, Peterson OL, Strauss E. Staphylococcic pneumonia occurring during an epidemic of influenza. Arch Intern Med 1942;70:183-205.
6. Reimann HA. Primary staphylococcic pneumonia. JAMA 1933;101:514-20.
7. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958;2:233-6.
8. Woodhead MA, Radvan J, MacFarlane JT. Adult community-acquired staphylococcal pneumonia in the antibiotic era: A review of 61 cases. Q J Med 1987;64:783-90.
9. Sanford JR, Pierce AK. Current infection problems. Proceedings of the International Conference on Nosocomial Infections. Chicago: American Hospital Association, 1971:77-81.
10. Thoburn R, Fekety FR Jr, Cluff LE, Melvin VB. Infections acquired by hospitalized patients. An analysis of the overall problem. Arch Intern Med 1968;121:1-10.
11. Garb JL, Brown RB, Garb JR, Tuthill RW. Differences in etiology of pneumonias in nursing home and community patients. JAMA 1978;240:2169-72.
12. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA 2000;283:749-55.
13. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
14. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH; Canadian Infectious Disease Society; Canadian Thoracic Society. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J 2000;7:371-82.
15. Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement - CLSI document M100-s16. Pennsylvania: CLSI, 2006.
16. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-32.
17. Mulvey M, Chui L, Ismail J, et al; Canadian Committee for the Standardization of Molecular Methods. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001;39:3481-5.
18. Bannerman TL, Hancock JA, Tenover FC, Miller JM. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995;33:551-5.
19. Julander I, Arneborn P, Back E, Hoglund C, Svanbom M. Intravenous drug addiction - staphylococcal septicemia - pulmonary embolism: A triad pathognomonic for tricuspid valve endocarditis? Scand J Infect Dis 1983;15:257-65.
20. Gonzalez C, Rubio M, Romero-Vivas J, Gonzales M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999;29:1171-7.
21. Cafferkey MT, Abrahamson E, Bloom A, Keane CT. Pulmonary infection due to methicillin-resistant Staphylococcus aureus. Scand J Infect Dis 1988;20:297-301.
22. Lentino JR, Hennein H, Krause S, et al. A comparison of pneumonia caused by gentamicin, methicillin-resistant and gentamicin, methicillin-sensitive Staphylococcus aureus: Epidemiologic and clinical studies. Infect Control 1985;6:267-72.
23. Rebhan AW, Edwards HE. Staphylococcal pneumonia: A review of 329 cases. Can Med Assoc J 1960;82:513-7.
24. Hiramatsu K, Niederman MS. Health-care-associated pneumonia: A new therapeutic paradigm. Chest 2005;128:3784-7.
25. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-7.
26. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
27. Lim WS, Macfarlane JT, Colthorpe CL. Treatment of community-acquired lower respiratory tract infections during pregnancy. Am J Respir Med 2003;2:221-33.
28. Rajan S, Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 2002;17:47-56.
29. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Staphylococcus aureus bacteremic pneumonia: Differences between community and nosocomial acquisition. Int J Infect Dis 2003;7:102-8.
30. Skull SA, Krause V, Coombs G, Pearman JW, Roberts LA. Investigation of a cluster of Staphylococcus aureus invasive infection in the top end of the Northeastern Territory. Aust NZ J Med 1999;29:66-72.
31. Tumbarello M, Tacconelli E, Lucia MB, Cauda R, Ortona L. Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. Respir Med 1996;90:531-7.
32. Musher DM, Lamm N, Darouche RO, Young EJ, Hamill RJ, Landon GC. The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine (Baltimore) 1994;73:186-208.
33. Tsao TC, Tsai YH, Lan RS, Shieh WB, Lee CH. Pulmonary manifestations of Staphylococcus aureus septicemia. Chest 1992;101:574-6.
34. Kaye MG, Fox MJ, Bartlett JG, Braman SS, Glassroth J. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest 1990;97:788-92.
35. Levine SJ, White DA, Fels AO. The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected human immunodeficiency virus. Am Rev Respir Dis 1990;141:89-93.
36. Watanakunakorn C. Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis 1987;19:623-7.
37. Naraqi S, McDonnell G. Hematogenous staphylococcal pneumonia secondary to soft tissue infection. Chest 1981;79:173-5.
38. Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine 1977;56:383-409.
39. Fisher AM, Trever RW, Curtin JA, Schultz G, Miller DF. Staphylococcal pneumonia. N Engl J Med 1958;258:919-28.
40. Hausmann W, Karlish AJ. Staphylococcal pneumonia in adults. Br Med J 1956;2:845-7.